Larvol Delta - Company-actively-evaluating-multiple-acquisition-opportunities-while-advancing-discussions-to-outlicense-its-legacy-glioblastoma-multiforme-programs-Berubicin-and-TPI287

TPI 287 - CNS Pharma

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://finance.yahoo.com/sectors/healthcare/articles/cns-pharmaceuticals-reports-first-quarter-120000474.html

May 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next